Parnassus Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-873,001
| Closed | -$76.2M | – | 131 |
|
|
2024
Q1 | $76.2M | Sell |
873,001
-976,347
| -53% | -$85.3M | 0.16% | 89 |
|
|
2023
Q4 | $178M | Sell |
1,849,348
-489,181
| -21% | -$47.2M | 0.4% | 51 |
|
|
2023
Q3 | $207M | Hold |
2,338,529
| – | – | 0.51% | 46 |
|
|
2023
Q2 | $203M | Hold |
2,338,529
| – | – | 0.47% | 46 |
|
|
2023
Q1 | $227M | Hold |
2,338,529
| – | – | 0.56% | 46 |
|
|
2022
Q4 | $242M | Sell |
2,338,529
-227,551
| -9% | -$23.5M | 0.6% | 43 |
|
|
2022
Q3 | $218M | Sell |
2,566,080
-215,340
| -8% | -$18.3M | 0.57% | 45 |
|
|
2022
Q2 | $230M | Buy |
2,781,420
+55,490
| +2% | +$4.6M | 0.55% | 47 |
|
|
2022
Q1 | $210M | Hold |
2,725,930
| – | – | 0.43% | 52 |
|
|
2021
Q4 | $241M | Buy |
2,725,930
+41,056
| +2% | +$3.63M | 0.46% | 54 |
|
|
2021
Q3 | $208M | Hold |
2,684,874
| – | – | 0.44% | 55 |
|
|
2021
Q2 | $224M | Hold |
2,684,874
| – | – | 0.49% | 50 |
|
|
2021
Q1 | $203M | Buy |
2,684,874
+1,165,923
| +77% | +$88M | 0.49% | 50 |
|
|
2020
Q4 | $133M | Buy |
1,518,951
+1,331,882
| +712% | +$117M | 0.36% | 62 |
|
|
2020
Q3 | $14.2M | Buy |
187,069
+97,349
| +109% | +$7.41M | 0.04% | 101 |
|
|
2020
Q2 | $11.1M | Buy |
+89,720
| New | +$11.1M | 0.04% | 104 |
|